Clinical Trial Update: Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluates ferumoxytol-enhanced MRI to assess renal vasculature and function in chronic kidney disease, and the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Feraheme (ferumoxytol)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Chronic Kidney Diseases | Phase 1 | Status: COMPLETED